STING-ATF3/type I interferon crosstalk: A potential target to improve anti-tumour immunity in chemotherapy-treated urothelial carcinoma

Alexandra Fauvre 1 , Margot Machu 1 , Audrey Merienne 2 , Nadia Vie 1 , Thomas Bessede 1 , Mathilde Robin 1 , Veronique Garambois 1 , Clara Taffoni 3 , Nadine Laguette 3 , Nadine Gervois-Segain 2 , Anne Jarry 2 , Nathalie Labarriere 2 , Yves Allory 4 , Christel Larbouret 1 , Laurent Gros 1 , Diego Tosi 1 , David B Solit 5 , Philippe Pourquier 1 , Nadine Houédé 1 , Celine Gongora 1

2024

Clin Transl Med .

/ pages 14(9):e70011.